The molecular actions of oestrogen in the regulation of vascular health

Experimental Physiology

Volumn 101, Issue 3, 2016, Pages 356-361

  Usselman, Charlotte W ^a   Stachenfeld, Nina S ^b   Bender, Jeffrey R ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; ENDOTHELIUM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; RISK REDUCTION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; VASCULARIZATION; ANIMAL; DRUG EFFECTS; HORMONE SUBSTITUTION; MENOPAUSE; PHYSIOLOGY; PROCEDURES; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MUSCLE, SMOOTH, VASCULAR;

EID: 84959358438     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085148     Document Type: Article

References (68)

1. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, Lacroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van HL, Wactawski-Wende J, Wallace R & Wassertheil-Smoller S; Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712.
2. Anon. (1995). Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273, 199-208.
3. Arnal JF, Fontaine C, Billon-Gales A, Favre J, Laurell H, Lenfant F & Gourdy P (2010). Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 30, 1506-1512.
4. Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P & Harper KD (2002). Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287, 847-857.
5. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA & Wenger NK (2006). Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355, 125-137.
6. Beldekas JC, Smith B, Gerstenfeld LC, Sonenshein GE & Franzblau C (1981). Effects of 17 beta-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 20, 2162-2167.
7. Bhalla RC, Toth KF, Bhatty RA, Thompson LP & Sharma RV (1997). Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 272, H1996-H2003.
8. 2+ mobilization. Circ Res 81, 885-892.
9. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J & Deanfield JE (1994). Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24, 471-476.
10. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RGW & Shaul PW (2000). Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87, E44-E52.
11. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19, 1034-1040.
12. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 26, 707-715.
13. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N & Ritter JM (1998). Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 32, 730-734.
14. Gilligan DM, Badar DM, Panza JA, Quyyumi AA & Cannon RO 3rd (1994). Acute vascular effects of estrogen in postmenopausal women. Circulation 90, 786-791.
15. Gisclard V, Miller VM & Vanhoutte PM (1988). Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244, 19-22.
16. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E & Wenger N (2002). Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288, 49-57.
17. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M & Barton M (2007). Differential effects of 17β-estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49, 1358-1363.
18. Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M & Hodis HN (2014). Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 161, 249-260.
19. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H & Ouchi Y (1995). Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92, 3431-3435.
20. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC & Bender JR (2003). Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278, 2118-2123.
21. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC & Bender JR (2000). Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87, 677-682.
22. Hisamoto K & Bender JR (2005). Vascular cell signaling by membrane estrogen receptors. Steroids 70, 382-387.
23. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N & Murata Y (2001). Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 276, 3459-3467.
24. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R & Saruta T (1995). Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360, 291-293.
25. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613.
26. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS & Mendelsohn ME (1997). Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3, 545-548.
27. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME & Shaul PW (2002). Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 91, 814-820.
28. Inaba Y, Chen JA & Bergmann SR (2010). Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging 26, 631-640.
29. Kanashiro CA & Khalil RA (2001). Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol Cell Physiol 280, C34-C45.
30. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JÅ, Korach KS, Smithies O & Mendelsohn ME (1999). Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA 96, 15133-15136.
31. Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian A & Hodis HN (2005). Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 12, 366-373.
32. Khalil RA (2013). Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. Biochem Pharmacol 86, 1627-1642.
33. Kim KH & Bender JR (2009). Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol 308, 3-8.
34. Kim KH, Toomre D & Bender JR (2011). Splice isoform estrogen receptors as integral transmembrane proteins. Mol Biol Cell 22, 4415-4423.
35. Kling JM, Lahr BA, Bailey KR, Harman SM, Miller VM & Mulvagh SL (2015). Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric 18, 187-197.
36. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ & Ritter JM (2000). Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36, 1233-1238.
37. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A & Virmani R (1996). Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol 148, 969-976.
38. Krasinski K, Spyridopoulos I, Asahara T, Van Der Zee R, Isner JM & Losordo DW (1997). Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95, 1768-1772.
39. Li L, Haynes MP & Bender JR (2003). Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100, 4807-4812.
40. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC & Creager MA (1994). Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 121, 936-941.
41. McNeill AM, Kim N, Duckles SP, Krause DN & Kontos HA (1999). Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30, 2186-2190.
42. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS & Shaul PW (1997). Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81, 355-362.
43. Mendelsohn ME (2000). Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 74, 337-343.
44. Mendelsohn ME & Karas RH (1999). The protective effects of estrogen on the cardiovascular system. N Engl J Med 340, 1801-1811.
45. Miller VM & Duckles SP (2008). Vascular actions of estrogens: functional implications. Pharmacol Rev 60, 210-241.
46. Miller VM & Mulvagh SL (2007). Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 28, 263-270.
47. Moriarty K, Kim KH & Bender JR (2006). Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147, 5557-5563.
48. Muesing RA, Forman MR, Graubard BI, Beecher GR, Lanza E, McAdam PA, Campbell WS & Olson BR (1996). Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet. J Clin Endocrinol Metab 81, 3599-3603.
49. Okano H, Jayachandran M, Yoshikawa A & Miller VM (2006). Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells. J Cardiovasc Pharmacol 47, 621-628.
50. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P & Mendelsohn ME (2002). Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 90, 1087-1092.
51. Rosenthal T & Oparil S (2000). Hypertension in women. J Hum Hypertens 14, 691-704.
52. Rossouw JE (1996). Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon. Circulation 94, 2982-2985.
53. Rossouw JE, Anderson GL, Prentice RL, Lacroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM & Ockene J (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
54. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW & Korach KS (1997). Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99, 2429-2437.
55. Russell KS, Haynes MP, Sinha D, Clerisme E & Bender JR (2000). Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97, 5930-5935.
56. Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK & Hinderliter AL (2007). Age moderates the short-term effects of transdermal 17β-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol 27, 1782-1787.
57. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB & Korach KS (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331, 1056-1061.
58. Stallone JN, Crofton JT & Share L (1991). Sexual dimorphism in vasopressin-induced contraction of rat aorta. Am J Physiol Heart Circ Physiol 260, H453-H458.
59. Stirone C, Chu Y, Sunday L, Duckles SP & Krause DN (2003). 17β-Estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol 478, 35-38.
60. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS & Rubanyi GM (1997a). Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96, 3774-3777.
61. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K & Rubanyi GM (1997b). Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349, 1146-1147.
62. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME & Green DJ (2011). Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 300, H2-H12.
63. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM & Pajak A (1994). Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583-612.
64. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pelliccia F, Volterrani M, Fini M, Collins P & Rosano GM (2008). Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 28, 348-352.
65. + channels. Circ Res 79, 1024-1030.
66. Ca channels through a cGMP-dependent mechanism. Circ Res 77, 936-942.
67. Williams MR, Westerman RA, Kingwell BA, Paige J, Blombery PA, Sudhir K & Komesaroff PA (2001). Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 86, 5389-5395.
68. i. J Biol Chem 276, 27071-27076.